• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·ADLINE.BO
Share

Adline Chem Lab Limited Stocks

₹ 15.79Last Updated 22.10.2026

Issuer Rating

Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 972671.895

₹ 15.79
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Adline Chem Lab Ltd. is a pharmaceutical company dedicated to producing a variety of medicinal products. Their extensive product range includes multivitamins, anti-infective medications, items for pregnancy and reproductive health, hemostatic agents, and hepatocare treatments. Laskari Kamlesh Jagdish established the company on July 6, 1988, and its main office is located in Ahmedabad, India.

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

27.10.2026 21:09

Delays in ramping up 737 Max production overshadowed Boeing's revenue growth. The stock plummeted.

27.10.2026 19:50

"More Greed Than Fear": How Anthropic's Upcoming IPO Has Restored Faith in AI Stocks

27.10.2026 18:51

Mercedes No Longer Expects Profit Growth: Sales in China Plummeted by 30%

27.10.2026 18:23

Oil Prices Fall: Investors Hope for a "Diplomatic Breakthrough"

27.10.2026 18:00

Black Cyber October: AI Has Eliminated the Hacker Shortage. How Is the Market Responding?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026